Dr. Fulkerson’s independent research program is focused on delineating the molecular program that orchestrates eosinophil development and functional responses. She has over 15 years of research experience working on eosinophil biology using both ex vivo functional assays and in vivo experimental models. Her overall aim is to identify novel therapeutic targets to block eosinophil production for the treatment of patients with eosinophilic disorders. In addition, Dr. Fulkerson’s clinical practice is focused on patients with eosinophil-associated disorders as a physician in the Cincinnati Center for Eosinophilic Disorders